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THE question of the involvement of the polycyclic hydrocarbons with sulphy-
dryl groups during the process of carcinogenesis has been under discussion for a
long time. Ceitain indirect evidence exists and has been reviewed by Crabtree
(1947), who concludes that the available evidence does not warrant any decision
as to whether the involvement is direct or not.
In other directions Mueller and Rusch (194t3) could obtain no effect upon
the activity of urease--this being dependent upon the integrity of the-SH
groups-with benzpyrene solution. On the other hand Rondoni and Bassi (1948)
have found benzpyrene to inhibit the papainaise digestion of gelatin and also
the cathepsins of rat sarcoma and horse liver. The non-carcinogenic hydro-
carbons, phenanthrene, anthracene and pyrene, had no action. Calcutt and
Newhouse (1948) also found that the photodynamic action of benzpyrene was
inhibited by cysteine hydrochloride.
Further work (Calcutt, 1948) showed that certain other -SH-containing
compounds were also effective as inhibitors of photodynamic action. In the
attempt to find the mechanism of this action it was found that after incubation
of a colloidal suspension of benzpyrene in a solution of cysteine hydrochloride
the characteristic yellow-green fluorescence colour of the benzpyrene changed to
pale blue. Preliminary attempts to isolate this blue fluorescing compound were
unsuccessful, but it was found that the mixture no longer gave a positive test
with sodium nitroprusside. This implied the inhibition of the -SH group of the
cysteine and formed the starting-point for further work.
The inhibition of -SH groups.
Using colloidal benzpyrene in distilled water, tests were carried out with a
series ofcompounds. In each case the technique was the same. Equal aniounts
of a solution of the sulphydryl-containing compound were placed in each of two
tubes. To one was added some benzpyrene colloid, and to the other an equivalent
amount of distilled water. Both were then incubated, and samples from each
were tested at intervals with nitroprusside. In this way it was found that
inhibition of the -SH of cysteine hydrochloride, thiomalic acid, thioglycollic acid
and 2-mercaptoethanol occurred in the tubes containing benzpyrene. In each
case the control tube continued to give a positive reaction with the nitroprusside.
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colour ofthe benzpyrene fromyellow-green topale blue., There was no apparent
fluorescence in the water which acted as the medium.
In the above ins'tances the reaction mixture was in each case acid. So the
investigation was extended to cover a greaterpH range. Using cysteine, sodium
thiomdlate, sodium thioglycollate solutions to which varying amounts of sodium
hydroxide solutions had been' added, it was found that inhibition occurred as
before. With slightly alkahne nlixtures, however, a small amount of blue
fluorescing compound was obtained in solution.
For allthe cases mentioned above incubation has to be continued forupwards
of 11 hours at a temperature of 65' C. before any inhibition became apparent.
Atlowertemperatures the action was very slow, and at roomtemperature-25' C.
-thereappeared to be no effect whatever.
Prelim'mary trials having indicated that caffeine solutions had fittle effect
upon -SH as detected by nitroprusside, some of the previous experiments were
repeated, using a solution ofbenzpyrene in a 3 per cent caffeine solution. Inhi-
bitionof-SH wasachieved asbefore, butthis timeinuch morerapidly-30 nlinutes
at 650 C.
Isolation ofthe reactionproducts.
Under the conditions so farinvestigated the yield of the pale blue fluorescing
product of the reactions has only been very small. Nevertheless it has been
found possible to isolate products from both the alkahne and acid reaction
rmxtures. The methods used and found suitable were those developed by
Weigert and Mottram (1946) andWeigert (1948) for theseparation ofbenzpyrene
metabolites as found in animals. In this way smallyields of solutions of appa-
tently pure substances were obtained, the final purifications being by repeated
chromato-graphv.
Propertie8o the reactionproducts.
To date insufficient material has been available for chemical analysis, but
certain general properties are apparent. From the alkahne reaction raixture a
watersolublecompound was derived. Thisis solubleinorganicreagents,strongly adsorb6d to silica, strongly adsorbed to alurnina, fluoresces a whitish-blue colour
in ultra-violet light. On addition of dilute acid it changes to a blue fluorescing compound which is soluble in organic reagents insoluble in water but soluble in
dilute alkali.
From the acid reaction mixture a com ound has been separated wliich is
soluble in organic reagents, soluble in dilute alka'li, insoluble in water, adsorbed
strongly to alumina and is weakly adsorbed to silica, moving down slowly as
elution is continued.
Thus in their physical properties these compounds show a remarkable simi-
larity to those separated from aninials and designated by Weigert and Mottrani
(1946) as BpX.,, BpFj aind BpF21 this latter apparently being identical with the
compound characterized by Berenblum, Crowfoot, Holiday and Schoental (1943)
as 8.OR Benzpyrene.
Examination of tlle fluorescence spectra of the derived compounds offers
further interest. That ofthe water soluble compound is found to be comparable 20§.308 G. CALCUTr
to that of BpX,, whilst the alkali soluble product derived by acidification gives
a spectrum similar to that ofBpF,. In this connection it must be recalled that
Weigert and Mottram (1946) found that acid hvdrolysis of BpX, gave rise to
BpF,.
The spectrum of the alkali soluble product from the acid reaction mixtiire
resembles that of BpF2 (8.OH.Bp). Furthermore it is found tllat continiied
RiG. I.-Fluorescence spectra of benzpyrene derivatives: (1) Benzpyrene X, from mouse.
(2) Water soluble compound from alkaline reaction n-iixture. (3) Ben,zpyrene Fl from
mouse. (4' Alkali soluble product from acidification of (2). (5) 8.OH benzpyrene from
mouse. (6) Alkali solubleproduct from acid reaction7mixture.
acid hydrolysis of the compound derived from the water soluble product gives
rise to a furtber compound, which from its general behaviour and fluorescence
spectrum appears to be identical with the product derived from the acid
reaction.
For purposes of comparison the fluorescence spectra of the compounds
obtained as above are shown together with those of BpX,, BpF, and Bff. in
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DISCUSSION.
The work described above indicates that 3 : 4-benzpyrene can engage in direct
chemical action with avariety ofcompounds containingsulphydryl. Furthermore
the evidence suggests a considerable parallelism, even if not identity, with the
course of events after the introduction of benzpyrene into the animal body.
Whilst the apparent identity of the fluorescence spectra does not-imply strict
cheniical identity, it does mean the very close relationship of the substances
concerned.
From this it is reasonable to suggest that the interaction ofbenzpyrene with
a -SH containing compound gives rise to a substance of the BpXj type. This,
bowever, is in the presence of acid successively broken to compounds of BpFj
and BpF2 type. It has already been suggested by Crabtree (1947) that the
detoxication ofbenzpyrene isby way of-SHcompounds. In view ofthe evidence
presented above this must now be regarded as being most probable.
Crabtree (1940, 1944, 1945) has as a result of his work with -SH inhibitors
suggested the involvement ofsulphur in carcinogenesis caused by the polycyclic
hydrocarbons. This is further reinforced by the recent work of Lusky, Braun
and Woodard (1947), who inhibited the carcinogenic action -of the benzpyrene
by application of B.A.L. (2:3-dimercaptopropanol). Additionally, evidence
has been put forward by Weigert, Calcutt and Powell (1947) to the effect that
detoxication occurs at the site of careinogenesis. Now in view of the above
eV'idence it appears most likely that detoxication and careinogenesis both occur
together, and that both processes are intimately concerned with sulphydryl.
Further evidence isrequired to reinforce the viewsexpressed above,andto this
end aninvestigation of a series ofcarcinogenic andnon-carcinogenichydrocarbons
has been started whilst work on the chemistry of the reactions described is con-
tinuing. So far the data available indicates that othercarcinogenichydrocarbons
react with -SH containing compounds in a fashion similar to benzpyrene, but
that the non-carcinogenic ones sbow no similar activity. Full details will be
published as soon as possible.
It is futile to speculate further on the role of sulphydryl in carcinogenesis,
but in conclusion it is perhaps interesting to recall that Potter (1943) has postu-
lated careinogenesis as arising by production of abnormal protein; Rondoni
(1948)suggests the action ofcarcinogenic agents OD nucleo- or liponucleo-protein,
whilst Powell (1946, 1947) has put forward a bypotbesis involving cytoskeletal
protein with particular reference to thiol groups. In any case, sulphydryl is
inextrieo.bly involved in discussions ofproteins.
SUMMARY.
An account is given of the conditions under which 3:4-benzpyrene is fo-Lind
to inhibit the -SH groups ofcysteine hydrochlroide, thiomalic acid, thioglycollic
-tcid and 2-mercaptoethanol. The isolation and further examination of reaction
products is described. On the basis of physical properties and fluorescence
spectra these products are sliown to be similar to the benzpyrene metabolites
obtained from animals. The relationship of the above findings to careinogenesis
and detoxication are discussed.
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